Results 11 to 20 of about 164,932 (165)

Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study [PDF]

open access: yes, 2018
Novel prognostic inflammatory markers of cancer survival and cardiovascular disease are; the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR) and the systemic immune-
Eijck, C.H.J. (Casper) van   +5 more
core   +1 more source

Ratios of lymphocyte and neutrophil to lymphocyte as early predictors of the severity of acute pancreatitis at different age stratifications

open access: yesEnvironmental Disease, 2020
Goal: To explore the values of lymphocyte ratio (LR) and neutrophil-to-lymphocyte ratio (NLR) in the early prediction of the severity of acute pancreatitis (AP) in patients of different ages. Background and Aims: LR and NLR, as early markers, can predict
Peng Liu   +7 more
doaj   +1 more source

Neutrophil to Lymphocyte Ratio in Preeclampsia

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2021
Objective: To determine the correlation between neutrophil to lymphocyte ratio and preeclampsia. To determine whether neutrophil to lymphocyte ratio can be used as a screening tool for preeclampsia.
Alfian Prasetyo   +2 more
doaj   +1 more source

Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: assessing prognostic and predictive value in SWOG 8710 [PDF]

open access: yes, 2017
No abstract ...
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration   +12 more
core   +1 more source

Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting [PDF]

open access: yes, 2007
Background: An elevated preoperative white blood cell count has been associated with a worse outcome after coronary artery bypass grafting (CABG). Leukocyte subtypes, and particularly the neutrophil-lymphocyte (N/L) ratio, may however, convey superior ...
Buchan, Keith G.   +9 more
core   +1 more source

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations

open access: yesDiabetes, Metabolic Syndrome and Obesity, 2021
Wenwen Chen,1,* Kun Chen,2,* Zhixiao Xu,3 Yepeng Hu,1 Yiying Liu,1 Wenyue Liu,1 Xiang Hu,1 Tingting Ye,1 Jing Hong,1 Hong Zhu,1 Feixia Shen1 1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou,
Chen W   +10 more
doaj  

Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and their association with the severity of depression and as biomarkers for suicidal behaviour among patients diagnosed with depression [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2023
Background: Depression has a significant impact on a person's quality of life and is a leading cause of death by suicide. Growing evidence points to a function for the immune and inflammatory systems in the pathophysiology of depression.
Swathi   +3 more
doaj  

Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative surgery for colon cancer [PDF]

open access: yes, 2009
<b>Aim</b>: To comprehensively compare the prognostic value of tumour and patient-related factors in patients undergoing curative surgery for colon cancer.
Benson   +41 more
core   +1 more source

Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report

open access: yesGynecologic Oncology Reports, 2023
Uterine leiomyosarcoma (LMS) is a gynecological malignancy with an extremely poor prognosis. Multiple new therapeutic agents, including pazopanib, trabectedin, and eribulin, have been clinically applied to treat uterine LMS, and their therapeutic effects
Motoki Matsuura   +6 more
doaj   +1 more source

Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study [PDF]

open access: yes, 2016
BACKGROUND: The phase III COntinuous or INtermittent (COIN) trial failed to show non-inferiority of intermittent compared with continuous chemotherapy for advanced colorectal cancer in overall survival (OS).
A Dirican   +13 more
core   +3 more sources

Home - About - Disclaimer - Privacy